Alnylam Pharmaceuticals shares owned by Standard Life Aberdeen
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Standard Life Aberdeen
from 13F filings
Historical chart of Standard Life Aberdeen investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Standard Life Aberdeen consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Alnylam Pharmaceuticals by Standard Life Aberdeen
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $72M | 157k | 455.67 |
| 2025-06-30 | $70M | 219k | 321.85 |
| 2025-03-31 | $57M | 215k | 264.90 |
| 2024-12-31 | $45M | 191k | 236.86 |
| 2024-09-30 | $55M | 200k | 274.90 |
| 2024-06-30 | $49M | 200k | 243.00 |
| 2024-03-31 | $33M | 219k | 149.45 |
| 2023-12-31 | $45M | 233k | 191.41 |
| 2023-09-30 | $4.1M | 23k | 177.10 |
| 2023-06-30 | $4.5M | 24k | 189.94 |
| 2023-03-31 | $4.7M | 24k | 200.32 |
| 2022-12-31 | $3.1M | 13k | 237.65 |
| 2022-09-30 | $2.4M | 12k | 200.15 |
| 2022-06-30 | $1.6M | 11k | 145.84 |
| 2022-03-31 | $1.8M | 11k | 163.92 |
| 2021-12-31 | $1.8M | 11k | 165.14 |
| 2021-09-30 | $2.0M | 11k | 188.79 |
| 2021-06-30 | $1.7M | 10k | 169.50 |
| 2021-03-31 | $1.7M | 12k | 141.25 |
| 2020-12-31 | $1.5M | 12k | 130.08 |
| 2020-09-30 | $1.7M | 12k | 145.70 |
| 2020-06-30 | $2.2M | 15k | 148.07 |
| 2020-03-31 | $1.6M | 14k | 108.89 |
| 2019-12-31 | $1.7M | 15k | 115.22 |
| 2019-09-30 | $1.1M | 13k | 80.40 |
| 2019-06-30 | $933k | 13k | 72.53 |
| 2019-03-31 | $1.1M | 12k | 93.47 |
| 2018-12-31 | $329k | 4.8k | 68.64 |
| 2018-09-30 | $424k | 4.8k | 87.55 |
| 2018-06-30 | $488k | 5.0k | 98.53 |